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Normal  regeneration  of the epidermis after a  split-thickness  injury requires 
mitosis and migration of epidermal cells from the residual epidermal appendages 
within the wound as well as from the intact epithelium surrounding the injury 
(1). Acceleration of epidermal regeneration by a pharmacologic agent may result 
in more rapid would healing.  Epidermal growth factor (EGF), a  well-described 
(2)  small  peptide  hormone,  is a  potent  mitogen  for human  epidermal  cells  in 
vitro  (3).  A  limited  number  of  clinical  and  experimental  attempts  to  show 
enhanced  epidermal  regeneration  of split-thickness  injuries  using  mouse  EGF 
have been unsuccessful (4-6). The purpose of this study was to evaluate the in 
vivo effectiveness of biosynthetic human  EGF obtained  from genetically engi- 
neered yeast  in  accelerating  epidermal  regeneration  in  split-thickness  wounds 
and partial-thickness burns in an experimental animal model. 
Materials and  Methods 
Reagents.  Human  EGF  (hEGF) was  produced  as  described (7).  Lanolin  was  from 
Squibb Pharmaceutical Co. (Princeton, N  J) and 1% silver sulfadiazine in a water-miscible 
base (Silvadene) was from Marion Laboratories (Kansas City, MO). 
Split-thickness Epidermal  Wounds.  84 split-thickness wounds (0.005 inches thick, 1 ×  1 
cm) were made on the dorsal thorax of four adult miniature pigs (Vim-Vet Laboratories, 
Marion,  ID).  Twice a  day,  28  wounds on each pig were treated with hEGF in cream 
(lanolin or Silvadene), 28 were treated with  the cream alone, and  28  were untreated. 
Four wounds from each group on each pig were randomly selected daily and entirely 
excised at a depth of 0.007 inches, including 5 mm of surrounding normal skin. Epidermis 
and dermis were readily separated from excised specimens after incubation in trypsin, 
and wounds were considered healed when no defect was present (8). 
Partial-thickness Burns.  A brass template (3 ×  5 cm, 430 g) was heated to 70°C in a 
constant-temperature water bath and then pressed for  10  s in contact with depiliated 
dorsal  skin  of Yorkshire  piglets  (14-20  pounds);  the  resultant  blister  was  removed. 
Histological evaluation of biopsy specimens confirmed that partial-thickness burns were 
produced. On each pig, two burns were treated twice a day with hEGF in Silvadene (0.5 
ml cream per square centimeter of burn), two burns were treated with Silvadene alone, 
and two were untreated. 
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FIGURE  I.  Effects of hEGF and vehicles on  healing of split-thickness wounds.  Each point 
represents the data from  16 wounds treated with hEGF (10 pg/ml) in the indicated vehicles, 
with vehicles alone, or with no treatment. Values were compared for statistical significance by 
X  2 analysis. WMB, water-miscible base (Silvadene). 
Identities of the creams were masked. After 7 d, the fibrinous coagulum was removed 
and burns were photographed. The percentage of the original burn area that was judged 
to be epithelialized was calculated by computerized planimetry of enlarged photographs. 
Results were analyzed by one-way analysis  of variance. Random biopsies were evaluated 
histologically for extent of epithelial regeneration. 
The effects of varying concentrations of hEGF on epithelial regeneration were evalu- 
ated using similar techniques.  10 burns (3  x  3 cm) were made on the dorsal thorax of 
individual Yorkshire piglets; one pair was treated twice daily with Silvadene alone, one 
pair was untreated. The remaining three pairs of wounds were treated twice daily, with 
one pair receiving 10 #g/ml hEGF Silvadene, one pair receiving 1 pg/ml, and one pair 
receiving 0.1 pg/ml. After 7 d, the extent of epithelial regeneration was determined. 
Results 
Split-thichness  Epidermal  Wounds.  As  shown  in  Fig.  1,  50%  of the  hEGF- 
lanolin-treated wounds (n =  16) were healed at 2 d, whereas the untreated and 
lanolin-treated control groups required >4 d  for 50% of the wounds to heal. All 
wounds in each group (n =  16) were healed by day 7. Similarly, 60% of wounds 
treated  with  hEGF  in  Silvadene  were  healed  at  2  d,  whereas  for  60%  of the 
untreated wounds and 60% of controls treated with Silvadene alone, >4 d  were 
required for the wounds to heal. All wounds were healed at the end of 1 wk. In 
both cases  the wounds  treated with  hEGF  significantly (p <  0.01)  accelerated 
epidermal  regeneration,  compared  with  untreated  wounds  or  wounds  treated 
with the creams alone. 
Of the wounds  that  healed, both control wounds and hEGF-treated wounds 
were similar in histologic appearance from 7 d, with no evidence of metaplastic 
transformation in the hEGF-treated wounds. All three groups showed a  10-12- 
cell layer of stratified squamous epithelium characteristic of normal pig skin. 
Partial-thickness  Burns.  A  representative photograph of the three treatment 
groups is shown in Fig. 2. After 7  d, virtually complete epidermal regeneration BROWN  ET  AL.  BRIEF  DEFINITIVE  REPORT  1321 
FIGURE 2.  Effects of hEGF and vehicles on healing of partial-thickness burns. A shows the 
gross appearance of 3 x  5 cm burns after 7 d of treatment with Silvadene (top burn), untreated 
(middle burn),  or  treated with hEGF (10  #g/ml)  in  Silvadene (bottom burn).  Microscopic 
histology of these burns is shown in panels B, C, and D, respectively. X 200. 
TABLE  I 
Effect  of hEGF and Vehicle on Healing of Partial-thickness Burns 
Treatment  Percentage of burn 
area healed 
hEGF  93 4- 6 
Control  36 4- 18 
Untreated  17 4- 11 
p <  0.01 using one-way analysis of variance and Tukey's Honest Statistical 
Difference (HSD) test. Quantitative planimetry measurements were per- 
formed on photographs of partial-thickness burns that were treated for 7 
d  with hEGF in Silvadene (10  #g/ml), Silvadene alone (control) or un- 
treated. Values are mean 4- SD for eight wounds. 1322  BROWN  ET  AL. 
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FIGURE 3.  Response of partial-thickness burns to varying doses of hEGF. Partial-thickness 
burns (3 x  3 cm) were treated for 7 d with Silvadene alone, Silvadene containing hEGF (10 
#g/ml,  1 #g/ml, 0.1  #g]ml), or were not treated. The percentage of original burn area that 
had healed was measured by quantitative planimetry of photographs.  Each data point is the 
mean ±  SD for four burns. WMB, water miscible base (Silvadene). 
occurred in partial-thickness  burns treated with hEGF in Silvadene, while sub- 
stantial  areas  of the  untreated  burns  or burns  treated  with  base cream  alone 
were not healed. Results of quantitative planimetry are shown in Table I. 
Biopsy specimens taken  7 d  after burn injury confirmed complete epidermal 
regeneration  in  those areas judged  to  be  healed  in  the  photographs  (Fig.  2). 
Regenerated epidermis of hEGF-treated burns showed stratification, prominent 
nucleoli within cells, limited intercellular edema, and a moderate dermal inflam- 
matory response that is typical of proliferating epidermis.  In contrast, very little 
epidermal regeneration  was observed in burns treated with Silvadene alone, or 
in  untreated  burns.  Biopsy specimens  taken  35  d  after  burn  injury  revealed 
normal  epidermal  and  dermal  architecture  in  all  groups  with  no  evidence of 
metaplasia in burns treated with hEGF. 
As shown in  Fig.  3,  all  concentrations  of hEGF,  as well as Silvadene alone, 
significantly  (p <  0.05)  increased  the  percentage  of healed  burn  surface area 
compared with untreated controls.  However, only burns treated with hEGF at 
10 #g/ml were significantly (p <  0.05) more healed than the burns treated with 
Silvadene alone. Histological evaluation of representative biopsy specimens con- 
firmed  the  complete epidermal  regeneration  in  areas judged  to  be  healed  in 
photographs of the burns. 
Discussion 
The mitogenic effect of EGF has been shown in vitro to require the continuous 
exposure of target cells to EGF for a  minimum  of 6-12 h  (9).  Previous studies BROWN  ET  AL.  BRIEF  DEFINITIVE  REPORT  1323 
(4-6), which failed to show an acceleration of healing by EGF for partial-thickness 
epidermal wounds,  may have  used conditions that  did  not provide  sufficient 
continuous exposure  of residual  epithelial  cells  to  EGF.  Greaves  (4)  applied 
mouse EGF at a final concentration of 50 #g/ml in saline to the base of suction 
blisters on volunteers for 5 min once daily, then the excess solution was removed 
and the areas were covered with sterile occlusive dressings. In a similar manner, 
Arturson (5) used either a single daily application of mouse EGF (0.5 mg/ml in 
saline) as a topical mist or a single daily intraperitoneal injection of EGF (3 #g/g 
body  weight)  for  treatment  of epidermal  wounds  made  in  rats  by  repeated 
strippings with adhesive tape or by immersion in 90°C water for 20 s. Thornton 
et al. (6) applied mouse EGF topically (1.5 #g/cm  2 burn surface area) as a  mist 
once daily, then applied Silvadene to partial-thickness burns produced on rats by 
immersion in 90 °C water for 5 s. All three of these studies reported no significant 
increase in epithelial regeneration by EGF treatment. In a separate set of pilot 
experiments, we also were unable to show an effect with hEGF applied topically 
in a mist or in saline to partial-thickness wounds (unpublished data). 
In  this  study,  hEGF  was  mixed with  topical  cream and the  mixtures were 
applied twice daily. The highly significant increase in healing of these wounds 
was most likely due to the creams providing more continuous exposure of residual 
epidermal cells to hEGF, and thus increasing their mitotic activity. Similar results 
have been obtained by others (L. Nanney, Vanderbilt Univ. Dept. of Surgery, 
personal  communication)  using  EGF  topically  for  the  treatment  of partial- 
thickness  wounds.  Also,  Buckley et  al.  (10)  recently reported  that  sustained 
release of EGF from subcutaneous pellets accelerated processes of wound repair 
in rats, whereas daily injections of EGF were much less effective. In an earlier 
study of full-thickness wound healing, Franklin and Lynch (11) applied mouse 
EGF in  a  water-miscible ointment to full-thickness wounds in rabbit  ears and 
reported a qualitative enhancement of  wound healing. In terms of understanding 
how EGF accelerates epidermal regeneration in vivo, Rhinewald and Green (3) 
showed that,  in  vitro,  EGF  recruits a  higher percentage of cells to  leave the 
resting state (Go) and enter and remain in the mitotic cycle. Assuming a similar 
effect of EGF on epidermal cells in vivo, the primary mechanism of enhanced 
wound healing produced by hEGF in  these experiments is most likely due to 
increased proliferation of epidermal cells. 
An important physiological distinction exists between healing of partial-thick- 
ness and full-thickness epidermal wounds: full-thickness wounds heal predomi- 
nantly by contracture, with epidermal regeneration playing a  minor role (12). 
There is evidence to suggest that EGF plays an important role in normal healing 
of full-thickness cutaneous wounds as well.  Removal of mouse submandibular 
glands,  which synthesize and secrete high levels of EGF,  reduced the rate of 
healing of full-thickness wounds in mice housed individually (13). Both repeated 
topical application of mouse EGF to the wounds or communal licking by intact 
mice promoted wound closure (14).  Other factors from mice submandibular 
glands,  such as  the protease  subunit  of the  high-mol-wt nerve growth factor 
complex, also may stimulate closure of full-thickness wounds (15,  16). 
Occlusive dressings, such as polyethylene film, have been shown (17) clinically 
to accelerate healing of selected partial-thickness injuries.  However, occlusive 
dressings are virtually limited to use on sterile skin graft donor sites, because 
they produce an environment favorable to increased bacterial growth. 1324  BROWN  ET  AL.  BRIEF  DEFINITIVE  REPORT 
Summary 
Epidermal  regeneration  depends  on  mitosis and  migration  of keratinocytes. 
Epidermal growth factor is known to stimulate growth of keratinocytes in vitro, 
thus it might be expected to promote wound healing.  The results of this study 
show  that  topical  application  of biosynthetic  human  epidermal  growth  factor 
accelerates epidermal regeneration in split-thickness wounds and partial-thickness 
burns.  The  significant  enhancement  of epidermal  regeneration  suggests  the 
potential for clinical use of epidermal growth factor for accelerating healing of 
burns, wounds from trauma, diabetic ulcers, skin graft donor sites, and others. 
Received for publication 30 October  1985. 
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